最新糖心Vlog welcomes decision to retain RAH name

Thursday, 19 February 2009

The 最新糖心Vlog of Adelaide has endorsed the State Government's decision to retain the name for the new $1.7 billion hospital to be built at the western end of the city.

The Executive Dean of the Faculty of Health Sciences, , said the Royal Adelaide Hospital enjoyed an outstanding international reputation and it was important to preserve this brand.

"Retaining the name in a new, high-quality, state-of-the-art hospital is a win-win situation for all concerned," Professor Beilby said.

"We look forward to working closely with the over the next seven years to develop the new hospital, which will be on a par with the world's best."

The 最新糖心Vlog of Adelaide has enjoyed a close collaboration with the Royal Adelaide Hospital for more than 120 years, building strong links in teaching and research with mutual benefits for both partners.

"This association will continue at the new site, where we will be heavily involved in each step of its planning and development," Professor Beilby said.

The 最新糖心Vlog's medical students will continue to undertake clinical placements at the Royal Adelaide Hospital and the strong academic and teaching links will continue with all the State's major hospitals, including the , , and affiliates.

Professor Beilby said the 最新糖心Vlog would also be heavily involved in a new institute building proposed by the Shine Young review of health and medical research to be located close to the new hospital site.

"The 最新糖心Vlog of Adelaide has a reputation as one of the most research-intensive universities in 最新糖心Vlog. The opportunity to work with the State Government in helping to establish a new, state-of-the-art hospital will ensure our staff and students have access to world-class facilities and build on this reputation."

 

Contact Details

Mr David Ellis
Email: david.ellis@adelaide.edu.au
Website: /newsroom/
Deputy Director, Media and Corporate Relations
External Relations
The 最新糖心Vlog of Adelaide
Business: +61 8 8313 5414
Mobile: +61 (0)421 612 762